The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Inflammatory mechanisms in ischemic stroke: therapeutic approaches
Open accessAbstract
Acute ischemic stroke is the third leading cause of death in industrialized countries and the most frequent cause of permanent disability in adults worldwide. Despite advances in the understanding of the pathophysiology of cerebral ischemia, therapeutic options remain limited. Only recombinant tissue-plasminogen activator (rt-PA) for thrombolysis is currently approved for use in the treatment of this devastating disease. However, its use is limited by its short therapeutic window (three hours), complications derived essentially from the risk of hemorrhage, and the potential damage from reperfusion/ischemic injury. Two important pathophysiological mechanisms involved during ischemic stroke are oxidative stress and inflammation. Brain tissue is not well equipped with antioxidant defenses, so reactive oxygen species and other free radicals/oxidants, released by inflammatory cells, threaten tissue viability in the vicinity of the ischemic core. This review will discuss the molecular aspects of oxidative stress and inflammation in ischemic stroke and potential therapeutic strategies that target neuroinflammation and the innate immune system. Currently, little is known about endogenous counterregulatory immune mechanisms. However, recent studies showing that regulatory T cells are major cerebroprotective immunomodulators after stroke suggest that targeting the endogenous adaptive immune response may offer novel promising neuroprotectant therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress
Nguyen, T., Nioi, P., & Pickett, C. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900010200 · Cited by 2,655
Donnan, G. A., Fisher, M., Macleod, M., & Davis, S. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60694-7 · Cited by 2,218
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
1,026 Experimental treatments in acute stroke
O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W. (2006) · Annals of Neurology · doi:10.1002/ana.20741 · Cited by 1,460
The role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272 · cited 1×
“There is substantial evidence that activated microglial cells in response to ischemia have the potential of releasing several pro-inflammatory cytokines such as TNFα, IL-1β, and IL-6, as well as other potential cytotoxic molecules including NO, ROS, and prostanoids [25].”
Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., & Veltkamp, R. (2009) · Nature Medicine · doi:10.1038/nm.1927 · Cited by 1,115
Cuzzocrea, S., Riley, D. P., Caputi, A. P., & Salvemini, D. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01484-4 · Cited by 1,087 · cited 1×
“Plenty of ROS are generated during an acute ischemic stroke and there is considerable evidence that oxidative stress is an important mediator of tissue injury in acute ischemic stroke [14].”
Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M. A., Fini, M. E., & Lo, E. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07724.2001 · Cited by 1,004 · cited 5×
“Neurons, astrocytes, microglia, and endothelial cells have all been shown to express MMPs after injury.”
InfluentialCentral nervous system injury-induced immune deficiency syndrome
Meisel, C., Schwab, J. M., Prass, K., Meisel, A., & Dirnagl, U. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1765 · Cited by 968
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
Barone, F. C., & Feuerstein, G. Z. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199908000-00001 · Cited by 930
Shichita, T., Sugiyama, Y., Ooboshi, H., Sugimori, H., Nakagawa, R., Takada, I., Iwaki, T., Okada, Y., Iida, M., Cua, D. J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1999 · Cited by 842
Regulatory T cells and mechanisms of immune system control
O'Garra, A., & Vieira, P. (2004) · Nature Medicine · doi:10.1038/nm0804-801 · Cited by 810
Brain inflammation and adult neurogenesis: The dual role of microglia
Ekdahl, C. T., Kokaia, Z., & Lindvall, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.052 · Cited by 801
Sharma, M. D., Baban, B., Chandler, P., Hou, D.-Y., Singh, N., Yagita, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 792
Functional Neuroimaging Studies of Motor Recovery After Stroke in Adults: A Review
Calautti, C., & Baron, J.-C. (2003) · Stroke · doi:10.1161/01.str.0000071761.36075.a6 · Cited by 751
NXY-059 for the Treatment of Acute Ischemic Stroke
Shuaib, A., Lees, K. R., Lyden, P., Grotta, J., Davalos, A., Davis, S. M., Diener, H.-C., Ashwood, T., Wasiewski, W. W., & Emeribe, U. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070240 · Cited by 732
Yamashita, T., Ninomiya, M., Hernandez Acosta, P., Garcia-Verdugo, J. M., Sunabori, T., Sakaguchi, M., Adachi, K., Kojima, T., Hirota, Y., Kawase, T., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0149-06.2006 · Cited by 715
Role of matrix metalloproteinases in delayed cortical responses after stroke
Zhao, B.-Q., Wang, S., Kim, H.-Y., Storrie, H., Rosen, B. R., Mooney, D. J., Wang, X., & Lo, E. H. (2006) · Nature Medicine · doi:10.1038/nm1387 · Cited by 702
Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke
Vila, N., Castillo, J., Dávalos, A., & Chamorro, A. (2000) · Stroke · doi:10.1161/01.str.31.10.2325 · Cited by 675
Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction
(2003) · Cerebrovascular Diseases · doi:10.1159/000069318 · Cited by 660
The Nrf2–ARE Pathway: An Indicator and Modulator of Oxidative Stress in Neurodegeneration
Johnson, J. A., Johnson, D. A., Kraft, A. D., Calkins, M. J., Jakel, R. J., Vargas, M. R., & Chen, P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.036 · Cited by 589
Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in Rats
Yamasaki, Y., Matsuura, N., Shozuhara, H., Onodera, H., Itoyama, Y., & Kogure, K. (1995) · Stroke · doi:10.1161/01.str.26.4.676 · Cited by 572
Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial
Enlimomab Acute Stroke Trial Investigators (2001) · Neurology · doi:10.1212/wnl.57.8.1428 · Cited by 544
O'Connor, J. C., André, C., Wang, Y., Lawson, M. A., Szegedi, S. S., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5032-08.2009 · Cited by 502
Role of IL-1α and IL-1β in Ischemic Brain Damage
Boutin, H., LeFeuvre, R. A., Horai, R., Asano, M., Iwakura, Y., & Rothwell, N. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05528.2001 · Cited by 477
Astrocyte Influences on Ischemic Neuronal Death
Swanson, R., Ying, W., & Kauppinen, T. (2004) · Current Molecular Medicine · doi:10.2174/1566524043479185 · Cited by 446
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients
Emsley, H. C. A. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054882 · Cited by 445
Minocycline treatment in acute stroke: An open-label, evaluator-blinded study
Lampl, Y., Boaz, M., Gilad, R., Lorberboym, M., Dabby, R., Rapoport, A., Anca-Hershkowitz, M., & Sadeh, M. (2007) · Neurology · doi:10.1212/01.wnl.0000277487.04281.db · Cited by 440
Krams, M., Lees, K. R., Hacke, W., Grieve, A. P., Orgogozo, J.-M., & Ford, G. A. (2003) · Stroke · doi:10.1161/01.str.0000092527.33910.89 · Cited by 430
Shih, A. Y., Li, P., & Murphy, T. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4014-05.2005 · Cited by 413
Cerebrovascular Disease: Pathophysiology, Diagnosis and Management
Ginsberg, M. D., & Bogousslavsky, J. (1998) · Medical Entomology and Zoology · Cited by 389
Absence of the Chemokine Receptor CCR2 Protects Against Cerebral Ischemia/Reperfusion Injury in Mice
Dimitrijevic, O. B., Stamatovic, S. M., Keep, R. F., & Andjelkovic, A. V. (2007) · Stroke · doi:10.1161/01.str.0000259709.16654.8f · Cited by 368
Zhang, R. L., Chopp, M., Li, Y., Zaloga, C., Jiang, N., Jones, M. L., Miyasaka, M., & Ward, P. A. (1994) · Neurology · doi:10.1212/wnl.44.9.1747 · Cited by 362
Montaner, J., Alvarez-Sabín, J., Molina, C., Anglés, A., Abilleira, S., Arenillas, J., González, M. A., & Monasterio, J. (2001) · Stroke · doi:10.1161/01.str.32.8.1759 · Cited by 350
IL-10 reduces rat brain injury following focal stroke
Spera, P. A., Ellison, J. A., Feuerstein, G. Z., & Barone, F. C. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00537-0 · Cited by 347
Monocyte Chemoattractant Protein-1 Deficiency is Protective in a Murine Stroke Model
Hughes, P. M., Allegrini, P. R., Rudin, M., Perry, V. H., Mir, A. K., & Wiessner, C. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200203000-00008 · Cited by 298
Kim, J. S., Gautam, S. C., Chopp, M., Zaloga, C., Jones, M. L., Ward, P. A., & Welch, K. M. A. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00138-e · Cited by 283
A Pilot Study of Normobaric Oxygen Therapy in Acute Ischemic Stroke
Singhal, A. B., Benner, T., Roccatagliata, L., Koroshetz, W. J., Schaefer, P. W., Lo, E. H., Buonanno, F. S., Gonzalez, R. G., & Sorensen, A. G. (2005) · Stroke · doi:10.1161/01.str.0000158914.66827.2e · Cited by 280
Cell adhesion molecules and ischemic stroke
Yilmaz, G., & Granger, D. N. (2008) · Neurological Research · doi:10.1179/174313208x341085 · Cited by 276
Endothelial ICAM-1 Expression Associated With Inflammatory Cell Response in Human Ischemic Stroke
Lindsberg, P. J., Carpe´n, O., Paetau, A., Karjalainen-Lindsberg, M.-L., & Kaste, M. (1996) · Circulation · doi:10.1161/01.cir.94.5.939 · Cited by 275
Increased Generation of Neuronal Progenitors after Ischemic Injury in the Aged Adult Human Forebrain
Macas, J., Nern, C., Plate, K. H., & Momma, S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4667-06.2006 · Cited by 274
Inflammation and ischaemic stroke
Muir, K. W., Tyrrell, P., Sattar, N., & Warburton, E. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32813ba151 · Cited by 264
Intrathecal release of pro- and anti-inflammatory cytokines during stroke
TARKOWSKI, E., ROSENGREN, L., BLOMSTRAND, C., WIKKELSÖ, C., JENSEN, C., EKHOLM, S., & TARKOWSKI, A. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1997.4621483.x · Cited by 225
Transforming Growth Factor-β1 Increases Bad Phosphorylation and Protects Neurons Against Damage
Zhu, Y., Yang, G.-Y., Ahlemeyer, B., Pang, L., Che, X.-M., Culmsee, C., Klumpp, S., & Krieglstein, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-03898.2002 · Cited by 224
(1996) · PubMed · Cited by 223
Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury
Soriano, S. G., Amaravadi, L. S., Wang, Y. F., Zhou, H., Yu, G. X., Tonra, J. R., Fairchild-Huntress, V., Fang, Q., Dunmore, J. H., Huszar, D., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00033-4 · Cited by 222 · cited 1×
“The level of a variety of chemokines has been found to increase in animal models of ischemia and their inhibition or deficiency has been associated with reduced injury [43-45].”
Crack, P., & Wong, C. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783330665 · Cited by 211
Increased Cytokine Release from Peripheral Blood Cells after Acute Stroke
Ferrarese, C., Mascarucci, P., Zoia, C., Cavarretta, R., Frigo, M., Begni, B., Sarinella, F., Frattola, L., & De Simoni, M. G. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199909000-00008 · Cited by 209
Rapid Morphologic Plasticity of Peri-Infarct Dendritic Spines After Focal Ischemic Stroke
Brown, C. E., Wong, C., & Murphy, T. H. (2008) · Stroke · doi:10.1161/strokeaha.107.498238 · Cited by 188
Lack of Interleukin-6 Expression Is Not Protective Against Focal Central Nervous System Ischemia
Clark, W. M., Rinker, L. G., Lessov, N. S., Hazel, K., Hill, J. K., Stenzel-Poore, M., & Eckenstein, F. (2000) · Stroke · doi:10.1161/01.str.31.7.1715 · Cited by 187
Safety and Tolerability of NXY-059 for Acute Intracerebral Hemorrhage: The CHANT Trial
Lyden, P. D., Shuaib, A., Lees, K. R., Davalos, A., Davis, S. M., Diener, H.-C., Grotta, J. C., Ashwood, T. J., Hardemark, H.-G., Svensson, H. H., et al. (2007) · Stroke · doi:10.1161/strokeaha.106.472746 · Cited by 174
The expression of P- and E-selectins in three models of middle cerebral artery occlusion
Zhang, R., Chopp, M., Zhang, Z., Jiang, N., & Powers, C. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01343-7 · Cited by 167
The Role of the Complement Cascade in Ischemia/Reperfusion Injury: Implications for Neuroprotection
D’Ambrosio, A. L., Pinsky, D. J., & Connolly, E. S. (2001) · Molecular Medicine · doi:10.1007/bf03402183 · Cited by 162
Endogenous Neurogenesis in the Human Brain following Cerebral Infarction
Minger, S. L., Ekonomou, A., Carta, E. M., Chinoy, A., Perry, R. H., & Ballard, C. G. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.1.69 · Cited by 158
Multiple Levels of Regulation of the Interleukin-6 System in Stroke
Acalovschi, D., Wiest, T., Hartmann, M., Farahmi, M., Mansmann, U., Auffarth, G. U., Grau, A., Green, F. R., Grond‐Ginsbach, C., & Schwaninger, M. (2003) · Stroke · doi:10.1161/01.str.0000079815.38626.44 · Cited by 144
Plasma and Brain Matrix Metalloproteinase-9 After Acute Focal Cerebral Ischemia in Rats
Park, K., Rosell, A., Foerch, C., Xing, C., Kim, W. J., Lee, S., Opdenakker, G., Furie, K. L., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.109.554824 · Cited by 141
Neuroprotection in stroke by complement inhibition and immunoglobulin therapy
Arumugam, T. V., Woodruff, T. M., Lathia, J. D., Selvaraj, P. K., Mattson, M. P., & Taylor, S. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.015 · Cited by 132
Brain-Mapping Techniques for Evaluating Poststroke Recovery and Rehabilitation: A Review
Eliassen, J. C., Boespflug, E. L., Lamy, M., Allendorfer, J. B., Chu, W., & Szaflarski, J. P. (2008) · Topics in Stroke Rehabilitation · doi:10.1310/tsr1505-427 · Cited by 97
Liu, X., Xia, J., Wang, L., Song, Y., Yang, J., Yan, Y., Ren, H., & Zhao, G. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02534.x · Cited by 91
P-selectin antibody reduces hemorrhage and infarct volume resulting from MCA occlusion in the rat
Goussev, A. V., Zhang, Z., Anderson, D. C., & Chopp, M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00262-7 · Cited by 85
Involvement of IL-1β in acute stress-induced worsening of cerebral ischaemia in rats
Caso, J. R., Moro, M. A., Lorenzo, P., Lizasoain, I., & Leza, J. C. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.009 · Cited by 84 · cited 1×
“Elevated IL-1β mRNA expression occurs within the first 15-30 min after permanent MCAO and elevated IL-1β protein expression occurs a few hours later and remains elevated for up to 4 days [ 32 ].”
IL-20 Is Regulated by Hypoxia-Inducible Factor and Up-Regulated after Experimental Ischemic Stroke
Chen, W., & Chang, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803653 · Cited by 83
Resveratrol, a Natural Antioxidant, Attenuates Intestinal Ischemia/Reperfusion Injury in Rats
Özkan, O. V., Yüzbaşıoğlu, M. F., Çıralık, H., Kurutaş, E. B., Yönden, Z., Aydin, M., Bülbüloğlu, E., Semerci, E., Göksu, M., Atlı, Y., et al. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.218.251 · Cited by 83
Time course of IL-6 expression in experimental CNS ischemia
Clark, W. M., Rinker, L. G., Lessov, N. S., Hazel, K., & Eckenstein, F. P. (1999) · Neurological Research · doi:10.1080/01616412.1999.11740933 · Cited by 81
Thrombolytic therapy in acute ischemic stroke
Furlan, A. J., Katzan, I. L., & Caplan, L. R. (2003) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-003-0001-4 · Cited by 74
Oxygen Therapy in Stroke: Past, Present, and Future
Singhal, A. B. (2006) · International Journal of Stroke · doi:10.1111/j.1747-4949.2006.00058.x · Cited by 68
Kumai, Y., Ooboshi, H., Takada, J., Kamouchi, M., Kitazono, T., Egashira, K., Ibayashi, S., & Iida, M. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000143534.76388.3c · Cited by 64
Gueorguieva, I., Clark, S., McMahon, C. J., Scarth, S., Rothwell, N. J., Tyrrell, P. J., Hopkins, S. J., & Rowland, M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03026.x · Cited by 63
Tirilazad for acute ischaemic stroke
The Tirilazad International Steering Committee (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002087 · Cited by 59
Advances in Computational Structure-Based Drug Design and Application in Drug Discovery
Wang, T., Wu, M.-B., Zhang, R.-H., Chen, Z.-J., Hua, C., Lin, J.-P., & Yang, L.-R. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150825142002 · Cited by 56
Yamagata, K., Ichinose, S., Miyashita, A., & Tagami, M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.028 · Cited by 53
Safety and tolerability of arundic acid in acute ischemic stroke
Pettigrew, L. C., Kasner, S. E., Albers, G. W., Gorman, M., Grotta, J. C., Sherman, D. G., Funakoshi, Y., & Ishibashi, H. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.09.001 · Cited by 37
van Breda, E. J., van der Worp, H. B., van Gemert, H. M. A., Algra, A., Kappelle, L. J., van Gijn, J., Koudstaal, P. J., Dippel, D. W. J., & the PAIS investigators (2005) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-5-24 · Cited by 35
Neuroprotection in Cerebral Infarction: The Opportunity of New Studies
de la Ossa, N. P., & Dávalos, A. (2007) · Cerebrovascular Diseases · doi:10.1159/000107391 · Cited by 31
Cited by
Neuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,428
Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy
Tian, T., Zhang, H.-X., He, C.-P., Fan, S., Zhu, Y.-L., Qi, C., Huang, N.-P., Xiao, Z.-D., Lu, Z.-H., Tannous, B. A., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.012 · Cited by 1,154
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke
Yang, C., Hawkins, K. E., Doré, S., & Candelario-Jalil, E. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00136.2018 · Cited by 871
Paul, S., & Candelario-Jalil, E. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113518 · Cited by 748
Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review)
Zhao, Y., Zhang, X., Chen, X., & Wei, Y. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5070 · Cited by 634
Metadata
- Authors
- Lakhan, S. E., Kirchgessner, A., & Hofer, M.
- Venue
- Journal of Translational Medicine
- Published
- 2009-11-17
- Volume
- 7
- Issue
- 1
- Pages
- 97-97
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W2150842829
- Cited by
- 1,072
- References
- 77
- FWCI
- 24.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.